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Many cells possess epithelial–mesenchymal plasticity (EMP), which allows
them to shift reversibly between adherent, static andmore detached,migratory
states. These changes in cell behaviour are driven by the programmes of
epithelial–mesenchymal transition (EMT) and mesenchymal–epithelial tran-
sition (MET), both of which play vital roles during normal development and
tissue homeostasis. However, the aberrant activation of these processes can
also drive distinct stages of cancer progression, including tumour invasive-
ness, cell dissemination and metastatic colonization and outgrowth. This
review examines emerging common themes underlying EMP during tissue
morphogenesis and malignant progression, such as the context dependence
of EMT transcription factors, a central role for partial EMTs and the nonlinear
relationship between EMT and MET.
This article is part of a discussion meeting issue ‘Contemporary
morphogenesis’.
1. Introduction
A key feature of tissue morphogenesis is the ability of cells to rapidly and rever-
sibly change their phenotype. This is termed cell plasticity and is exemplified by
the shift of polarized epithelial cells to an unpolarized migratory mesenchymal
state, and vice versa (figure 1). This epithelial–mesenchymal plasticity (EMP) is
underpinned by the processes of epithelial–mesenchymal transition (EMT) and
mesenchymal–epithelial transition (MET). Both EMTs and METs are crucial for
the migration and organization of many cell types into tissues and organs
during embryogenesis [1]. They also play key roles in homeostatic contexts,
such as during wound healing [2] and tissue renewal [3]. However, when acti-
vated inappropriately these processes can contribute to the progression of many
diseases, including cancer and fibrosis.
Cancer metastasis is a complex, multistage process, and there is increasing
evidence suggesting that cancer cells co-opt this plasticity, critical to healthy
development, to accomplish several of these steps. EMTs enable the escape of
cells from primary tumours, and their dissemination throughout the body,
and can also confer some degree of stemness on cancer cells [4]. Upon their
arrival at a distant site, METs have been shown to promote the overt outgrowth
of secondary metastases [5]. Metastasis remains the most deadly phase in the
malignant progression of a tumour, as well as the most poorly understood [6].
Therefore, increasing our understanding of the cellular and molecular mechan-
isms underlying epithelial plasticity during development, and investigating
parallels with cancer processes, will likely aid in the identification of novel
prognostic and therapeutic markers. This review will discuss the parallels
between EMP during tissue morphogenesis and in cancer progression, and
highlight how developmental systems can be a window into this aspect
of pathogenesis.
© 2020 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
2. Principles of epithelial plasticity
During development, mature epithelial cells exist on a spec-
trum from cells possessing only apicobasal polarity and
nascent junctions, to highly differentiated cells with elaborate
cell–cell junctions and specialized apical features, such as
brush borders and cilia [7]. Epithelial cell–cell adhesion is
oftenmediated through intercellular junctions comprising pro-
teins such as E-cadherin and ZO-1, providing a method for
signalling between epithelial cells, as well as a barrier necess-
ary for tissue or organ function [8]. Apicobasal polarity is
required for asymmetry of function, such as absorption and
secretion, and is defined by the mutually exclusive localization
of multiple protein complexes at the apical and lateral domains
of the cell [9]. The specific arrangement and composition of
these junctions and polarity complexes differs between cell
type and species, resulting in a diversity of function between
different tissues. The adhesion of mature epithelial cells to a
basement membrane provides additional mechanical support
to the tissue, and allows further signalling to occur to dictate
cell function, such as through the basally localized integrin
complexes [10].
By contrast, mesenchymal cells lack stable cell–cell
adhesion and apical–basal polarity, instead adopting a front–
rear polarity. These properties, in addition to differences in
cytoskeletal organization and interaction with the extracellular
matrix, confer a greater migratory capacity on these cells than
their epithelial counterparts [11].
EMT was first identified as a process through which cells
that are born far from their final destination are able to delam-
inate, migrate and populate different regions of the embryo
[12]. It was only with the later discovery of the EMT-inducing
transcription factor Slug that EMTwas proposed to play a role
in pathogenesis, based in part on the parallels between delami-
nation and tissue escape in the chick mesoderm and cancer
metastasis [13]. The Slug-related transcription factor Snail
was later shown to be activated in dedifferentiated carcinomas,
inducing a cellular transition similar to that described
previously in the embryo [14].
Since then, a number of evolutionarily conserved transcrip-
tion factors have been found to induce EMT, including other
genes in the Snail family, zinc-finger E-box-binding (ZEB)
family and basic helix–loop–helix (bHLH) family. These
encompass the core EMT transcription factors (EMT-TFs),
which include Snail/Slug, ZEB1/ZEB2 and Twist1, respect-
ively [11]. Many EMT-TFs were first identified for their role
in tissue morphogenesis. For example, Snail and Twist were
initially characterized as key regulators of Drosophila gastru-
lation [15,16], ZEB1 as a transcriptional regulator enriched in
mesodermal regions following gastrulation in chick embryos
[17], and mouse Prrx1 mutants were first analysed in the
context of skeletal formation deriving from the cranial neural
crest (NC) and mesoderm [18]. These transcription factors act
by downregulating the epithelial characteristics of cell–cell
adhesion and apicobasal polarity, and by enhancing the
migratory capacity of the resulting mesenchymal cells. The
reduction in intercellular adhesion is perhaps best represented
by the ability of most EMT-TFs to repress the expression of E-
cadherin, disrupting the adherens junctions [14,19]. Both
Snail and ZEB1 are also able to suppress the expression of
the apically localized polarity protein Crumbs3 and its ortholo-
gues, providing a conserved mechanistic link between
transcription factor activation and the disassembly of
apicobasal polarity as well as adherens junctions [20].
These transcription factors, while all possessing the capacity
to induce EMT in specific circumstances, differ in their domain
structures, mechanisms of action and regulation, resulting in
diverse and non-overlapping functions and expression patterns
in development [21]. An example is seen during Drosophila
gastrulation, where the EMT-TF Snail induces EMT in the
mesoderm by disrupting adherens junctions through
the repression of E-cadherin transcription [22,23]. By contrast,
the EMT underlying endoderm morphogenesis does not
depend on Snail activity [24,25], instead relying on the GATA
factor Serpent [26]. Furthermore, Serpent does not repress
E-cadherin, which remains transcriptionally active in the endo-
derm, instead disrupting apicobasal polarity and adherens
junctions through the direct repression of crumbs [26].
apical
basal
epithelial mesenchymal
EMT
MET
Figure 1. EMT and MET mediate dynamic and reversible changes along a spectrum of intermediate epithelial–mesenchymal phenotypes. Mature epithelial cells
(yellow) are characterized by apicobasal polarity, lateral cell–cell junctions such as adherens junctions, gap junctions or tight junctions, and adhesion to a basement
membrane (brown). Mesenchymal cells (blue) exhibit front–rear polarity, lack cell–cell adhesions and migrate individually following detachment from the basement
membrane. Cells with intermediate phenotypes, induced via partial EMT, can simultaneously possess both mesenchymal and epithelial features, and often migrate as
a collective owing to the retention of intercellular adhesion. This diagram acts as an exemplar for the continuum of EMT states, but will differ between tissue
contexts in vivo depending on the maturity of epithelial cells, junctional arrangements, basal adhesion and modulation of the EMT programme.
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Differing spatio-temporal expression patterns and functions
of EMT-TFs are also observed during EMT and migration of
neural crest (NC) cell populations duringnervous systemdevel-
opment in vertebrates [27]. In Xenopus, the first cephalic NC
cells express Twist and migrate extensively to the ventral side
of the head to form cartilage [28]. However, the peripheral ner-
vous system is formed in part through themigration of a second
cephalic NC population to the dorsal side of the head, which
instead relies on Snail2 expression [29]. In chick, the trunk NC
cells undergo EMT from the dorsal neural tube all along the
anteroposterior axis. At any given position along this axis,
EMT occurs for 48 h, resulting in two populations of trunk
NC cells. During the first 24 h, an initial NC population
migrates to form the peripheral nervous system, and expresses
both Snail2 and ZEB2. Following this, Snail2 is no longer
expressed in the neural tube, resulting in the delamination
and migration of a second population which expresses only
ZEB2 [30], later differentiating into melanocytes. These two
populations take different migratory paths, with the first
migrating through the paraxial mesoderm and the second
following a dorsal trajectory under the endoderm, and also
migrate at differing cell densities. The EMT-TF expression pat-
terns of these two trunk NC populations contrast with the
chick cephalic NC, where the combined action of Snail2 and
Ets1 promote EMT and migration [31,32].
Many EMT-TFs first identified for their role in develop-
ment have been found to be reactivated at the invasive front
of carcinomas [33–35] and are required for metastasis. These
EMT-TFs not only act through similar cellular and molecular
mechanisms to those deployed during development, but also
display a level of context dependence that has only recently
been fully appreciated in the study of cancer. For example,
the ability of cells in a pancreatic cancer model to undergo
metastasis and form secondary tumours in the absence of
Snail was used as evidence that EMTs are not required for
metastasis [36]. However, a later study showed that, while
Snail is indeed dispensable for metastasis in this pancreatic
cancer model, the depletion of ZEB1 strongly affected EMP
and metastatic potential [37]. Furthermore, endogenous Snail
has been shown to be important for metastasis in the
MMTV-PyMT-driven breast cancer model and is associated
with mesenchymal features in tumour cells [33]. Taken
together, these studies demonstrate that, as in development,
the EMT-TF involved is dependent upon the tissue context.
The environmental and epigenetic circumstances within
which a tumour forms, as well as the type of epithelium, can
also affect the propensity of tumour cells to undergo EMT.
This is exemplified by recent findings that tumorigenesis
induced through the same oncogenic insults resulted in
epithelial tumours in the skin epidermis, but tumours under-
going EMT in the hair follicle [38]. Analysis of chromatin
state and gene transcription in both of these tissues, and in
their tumorigenic counterparts, revealed that the hair follicle
lineage was primed to express multiple TFs associated with
EMT induction [38]. Several of these EMT-TFs, such as
Runx1 and Tbx1, have established roles in hair follicle stem
cell homeostasis [39,40], suggesting that their expression or
priming in non-tumorigenic cells is linked to developmental
functions that are then aberrantly used by tumour cells.
When this observed context-specificity for EMT induction is
paired with the fact that the EMT-TFs employed differ
between developmental systems, it raises the possibility that
the mechanisms for EMT and MET used during cancer
progression in a specific tissue may mirror those used by
that tissue during development.
3. The spectrum of EMT in development
and cancer
While initial studies of EMT considered it to be a binary process
during which a mature epithelial cell transitions to a fully
mesenchymal phenotype, an increasing number of studies
have demonstrated that EMT can occur to differing extents,
resulting in a spectrum of cell types coexpressing a variety of
epithelial and mesenchymal characteristics [2,7,11]. These so-
called partial EMTs are prevalent in development, and can
arise from two considerations. The first is that the complexity
and maturity of the initial epithelium upon EMT onset deter-
mines to what extent a full EMT would need to occur before
cells were considered fully mesenchymal; the second is that
the EMT programme can be undertaken incompletely [7]. The
incomplete transition to amesenchymal cell occurs innumerous
developmental systems, and often results in the maintenance of
partial cell–cell junctions (figure 1). This simultaneous adoption
of migratory capacity while maintaining intercellular adhesion
is associated with the collective migration of many cell
populations [7].
A developmental example of a partial EMT resulting
in collective migration of a heterogeneous cell type is the
formation of the Drosophila embryonic midgut (figure 2a).
During embryogenesis, endodermal epithelial populations at
the anterior and posterior poles, termed the anterior and pos-
terior midgut primordia, undergo an EMT which facilitates
their collectivemigration through the embryo [24]. This process
is accompanied by the differentiation of endodermal cells into
three distinct populations that migrate in coordination with
one another along the underlying mesoderm [25,41–43]. The
largest of these three populations are the principal midgut
epithelial cells (PMECs), which later undergo MET to form a
monolayered epithelium, while the other two populations
retain mesenchymal morphology [41]. The EMT undertaken
prior to collective migration of the Drosophila posterior
midgut is also considered partial, as E-cadherin is not wholly
repressed and remains partially localized to the plasma mem-
brane in a punctate fashion [26]. These punctae are required for
the migration of this otherwise-mesenchymal cell population,
as depletion of E-cadherin results in the loss of cell–cell cohe-
sion during collective movement [43]. This partial EMT is
induced through the activation of the GATA transcription
factor Serpent, which drives a loss of apicobasal polarity and
fragmentation of adherens junctions through the direct
repression of crumbs [26]. This role for Serpent has been demon-
strated to be conserved by its mammalian orthologues GATA4
and GATA6 in canine kidney cells [26], and GATA6 upregula-
tion has been linked to tumorigenesis in multiple tissues
[44,45]. However, GATA6 has conversely been found to sup-
press EMT in pancreatic cancer cells, suggesting divergent
roles in different tissue contexts and underscoring the impor-
tance of studying gene function in multiple developmental
systems [46].
A common aspect linking developmental models for
partial EMT and collective migration is the maintenance of
E-cadherin expression. Though EMT-TFs are capable of repres-
sing E-cadherin [14,19], and its loss is considered a hallmark of
the mesenchymal state, it has become increasingly clear that
royalsocietypublishing.org/journal/rstb
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the spectrum of EMT states begets a spectrum of E-cadherin-
mediated adhesion states. Indeed, in the migration of both
the posterior midgut and the border cell cluster in the Droso-
phila egg chamber, the presence of E-cadherin is required for
maintenance of migratory cell clusters, as border cell-specific
depletion results in cluster disassembly, and the disruption of
E-cadherin in migrating posterior midguts results in the
detachment of otherwise-collective mesenchymal cells from
one another [43,47]. The expression and functional relevance
of E-cadherin in cells undergoing a partial EMT can also be
observed during vertebrate development, as the collective
migration of the zebrafish mesendoderm and the Xenopus
cranial NC both rely upon continued intercellular adhesion
conferred by E-cadherin [48,49]. Furthermore, though the
downregulation of E-cadherin and expression of N-cadherin
is required to establish collective migration in the Xenopus cra-
nial NC, residual levels of E-cadherin protein still remain on the
membrane of these cells, indicating that its repression is not
absolute [50]. This low level of E-cadherin expression is still
required for migration of cranial NC cells, though its knock-
down does not affect cell–cell adhesion within the collective,
potentially reflecting a function in adhesion of the cranial NC
to the adjacent placode cells [51]. Moreover, an examination
of the expression pattern of E-cadherin inmouse and chick cra-
nial NC cells showed that E-cadherin protein perdures during
delamination and early migration, though the functional rel-
evance of this has yet to be investigated [30,52]. These data
suggest that the maintenance of E-cadherin expression
epithelial
cancer metastasis
chick somitogenesis
Drosophila midgut morphogenesis
cell aggregationEMT and cell migration
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mesenchymal
cell migration
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MET
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Figure 2. Successive rounds of EMT and MET take place in development and cancer. (a,b) Several developmental examples exist in which both EMT and MET of the
same cell population can be studied. (a) Drosophila embryonic midgut morphogenesis. Midgut cells at both the anterior and posterior of the embryo are initially
epithelial (yellow). These cells then undergo a partial EMT (green), which facilitates their collective migration through the embryo. The majority of these migrating
cells subsequently undergo MET to form a contiguous midgut epithelium. The compass indicates the anterior–posterior and dorsal–ventral axes. (b) Chick
somitogenesis. The upper row of diagrams shows transverse cross sections. Sectioned regions are indicated by dotted lines on the lower row of diagrams, which
depict a dorsal view of the embryo. Epithelial cells (yellow) at the primitive streak first undergo EMT to form mesenchymal mesoderm progenitors (blue). The paraxial
mesoderm cells (blue) then undergo migration towards the anterior of the embryo to form the presomitic mesoderm (green). The presomitic mesoderm undergoes MET
during segmentation to form somites. Mature somites consist of epithelial cells (yellow) enclosing mesenchymal cells (blue). (c) EMT and MET underlie distinct stages of
tumour metastasis. Cancerous epithelial cells proliferate and can undergo partial or full EMT to form heterogeneous tumours (coloured) within an otherwise non-
cancerous tissue (grey). Tumours also recruit other, non-cancerous cells to facilitate growth and invasion, such as tumour-associated fibroblasts (orange). Migratory
cancer cells can escape the tissue via individual or collective migration and enter the circulatory system as individual cells or as clusters, dependent on EMT state.
Metastatic colonization of secondary sites requires re-epithelialization of the tumour cells through MET, resulting in the formation of secondary tumours.
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following induction of EMT programmes may be more
widespread than previously envisaged.
The initial assessment of EMT as a binary transition
between two end states resulted in controversy regarding the
role of EMT in cancer progression, as there was insufficient
evidence from clinical samples for such a full transition [53].
However, mirroring studies in development, it has become
increasingly clear that EMT in cancer is often partial, resulting
in tumour cells simultaneously adopting features of both
epithelial and mesenchymal cells [4].
The advent of single-cell technologies has allowed partial
EMTs to be identified in unprecedented resolution. The first
such example found that induced tumours in themouse hair fol-
licle—previously shown to exhibit properties of EMT [38]—
contained several different subpopulations of cells undergoing
varying levels of EMT [54]. These populationswere spatially dis-
tinct within the tumour mass, and populations undergoing a
partial EMT possessed a greater metastatic potential than their
epithelial or mesenchymal counterparts, recapitulating in vitro
data on the clinical relevance of incomplete transitions between
these two states [54]. Mass cytometry of high-grade serous
ovarian cancer tissue identified cell populations simultaneously
expressing both E-cadherin and the mesenchymal marker
vimentin, with some of these populations being associated
with metastasis following patient relapse [55], while mass cyto-
metric studies of lung cancer cell cultures identified a spectrum
of EMTprofileswhich could alsomap to cell populationswithin
patient tissue [56]. These in vitro and in vivo analyses, when
considered cumulatively, suggest a strong association between
partial EMT states and greater metastatic capacity and the
resultant prognosis in a multitude of different carcinomas [57].
The increasing evidence for the adoption of partial EMT
states by multiple tumour cells has been accompanied by a re-
evaluation of the role of E-cadherin in invasion and metastasis.
Early studies found that E-cadherin expression was often
ablated in breast cancer [58], and was depleted in cells at the
invasive front in colorectal cancer tissues [59]. Repression of
E-cadherin was further correlated with increased tumour
migration and metastatic capacity in vitro and in a mouse
breast cancer model [60,61], suggesting a functional link
between E-cadherin downregulation and cancer progression.
However, this perturbation of E-cadherin does not appear to
be universally required for metastasis. An elegant study under-
taken using MMTV-PyMT mice and organoids showed that,
though loss of E-cadherin increased the invasive potential
of tumour cells in three-dimensional invasion assays, transplan-
tation of E-cadherin mutant tumour organoids into mice
resulted in an almost-complete ablation of metastatic poten-
tial compared with their wild-type tumour counterparts [62].
E-cadherin mutant organoids also formed significantly fewer
macrometastases than wild-type when injected directly into
tail veins, indicating that this discrepancy in colonization
was independent of their ability to escape from the primary
tumour. Consistent with this implication, E-cadherin mutant
cells exhibited increased proportions of apoptosis mediated
by reactive oxygen species, suggesting a novel function for
E-cadherin beyond its well-established role in adhesion [62].
Other studies of E-cadherin in tumour invasion and meta-
stasis have identified more nuanced relationships. In a mouse
pancreatic ductal adenocarcinoma model, genetic manipu-
lation of the E-cadherin interacting partner p120-catenin was
used to demonstrate that E-cadherin expression and epithelial
statuswere associated primarilywith livermetastases,whereas
disruption of E-cadherin shifted metastatic colonization to the
lungs [63]. The authors suggest that this difference stems from
an inability for cells in a fullymesenchymal state tometastasize
to the liver, whereas cells having undergone partial EMT are
capable of forming both liver and lung metastases. A separate
examination of EMT states in a mouse pancreatic cancer model
revealed that partial EMT was mostly driven by a mechanism
that is independent of EMT-TF-mediated transcriptional
repression, whereby E-cadherin was internalized and seques-
tered in vesicles through endocytosis [64]. The same
mechanism was also identified in both colorectal and breast
cancer cell lines, indicating it may be awidespread programme
activated during tumour dissemination, though it has yet to be
identified in breast or colorectal tumours in vivo [64]. This par-
tial EMT induction through E-cadherin relocalization has
numerous parallels with tissue morphogenesis. During both
Drosophila posterior midgut migration and zebrafish epiboly,
E-cadherin is endocytosed as opposed to transcriptionally
repressed, limiting its presence on the plasma membrane
[43,65]. Interestingly, during sea urchin mesoderm formation,
Snail activity is required for both the endocytosis of
E-cadherin and for its transcriptional repression, indicating
that these two modes of EMT induction need not be mutually
exclusive in all circumstances [66]. It is possible that, as in sea
urchin embryogenesis, future investigations will identify
cancers in which both E-cadherin relocalization and transcrip-
tional repression are deployed, further adding to the spectrum
of partial EMTs identified during tumorigenesis.
Given the numerous developmental models of partial EMT
that are twinned with collective migration, it is unsurprising
that many cancer cells migrate as a collective [67]. Collective
cell migration has been linked to the retention of certain epi-
thelial characteristics such as intercellular adhesion in cancer
using both three-dimensional cell culture and MMTV-PyMT
mousemodels, as it has been demonstrated that cells expressing
epithelial markers such as cytokeratin 14 and E-cadherin act as
leader cells during this migration [68,69]. Additionally, in a
Drosophilametastatic tumour model in which EMT is activated,
cells maintained E-cadherin expression and escaped from the
primary tissue as a collective [70]. However these studies, and
also studies of clinical samples exhibiting collective migration
[71,72], rely on sample fixation and therefore do not allow the
examination of migratory speed, heterogeneity or regulation
of collective tumour cells in vivo. Furthermore, there are cur-
rently limited models for murine intravital imaging capable of
consistently detecting tumour collective migration [73], compli-
cating analysis of migratory cell dynamics. The use of
developmental models may circumvent this issue, owing to
their ease of imaging and genetic tractability. Given that clusters
of circulating tumour cells (CTCs) have a far greater potential
for seeding secondary metastases than single cells [74], under-
standing the dynamics of their movement and the
mechanisms mediating their adhesion may aid the develop-
ment of treatments targeted at cluster dissociation, as will be
discussed in the next section.
4. Partial EMT, adhesion and circulating
tumour cells
Following escape from the primary tissue, migrating tumour
cells can enter the circulatory system to reach distant sites in
the body. When present in the bloodstream these cells are
royalsocietypublishing.org/journal/rstb
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termed CTCs, and represent an intermediate step between
primary tumour dissemination and metastatic colonization
(figure 2c). While examination of blood from breast cancer
patients found that the majority of CTCs migrate individually,
a small proportion were capable of migrating as clusters of
cells expressing a combination of epithelial and mesenchymal
markers, indicative ofpartial EMT [75].Multiple lines of analysis
suggest that clusteredCTCs escape the primary tumour as a col-
lective as opposed to aggregating during circulation, providing
further support for the role of partial EMT in forming CTC clus-
ters [76]. The formation of CTC clusters is of clinical interest
given that clusters have a significantly greater metastatic poten-
tial than single CTCs in spite of their rarity [74], owing in part
to their resistance to apoptosis [62,74], and are accordingly
associated with poor prognosis in multiple cancers [77].
Understanding CTC adhesion could prove informative for
the development of treatments aiming to limit metastasis
through cluster dissociation. Encouragingly, several adhesion
molecules have already been identified in these clusters,
many of which are associated with epithelial cell fate.
E-cadherin has been identified at the point of cell–cell contact
within these clusters in a mouse model of pancreatic cancer
[64], and is also expressed in CTC clusters in a mouse breast
cancer model [62]. Though cells lacking E-cadherin in the pan-
creatic cancer model migrated individually, breast cancer CTC
clusters could be identified that lacked E-cadherin expression,
indicating that its depletion is not necessarily sufficient to
block CTC clustering [62,64]. Interestingly, a recent study of a
squamous cell carcinoma model found that claudin-11
expression was correlated with collective migration and CTC
cluster formation, and its expression was driven in
this context by the EMT-TF Snail, providing an additional
mechanistic link between EMT onset and poor prognosis [78].
Single-cell RNA sequencing of patient-derived breast cancer
CTC clusters also found that the adherens junction- and desmo-
some-associated protein plakoglobin was upregulated in
clustered cells, and that its knockdown resulted in cluster
dissociation [74].
The adhesion glycoprotein CD44 is also expressed in breast
cancer CTC clusters, and its depletion blocked the aggregation
of cells and was associated with decreased metastatic potential
following injection of treated cells into mice [79]. The identifi-
cation of upregulated CD44 was particularly interesting
given CD44 is commonly used as a marker for stemness prop-
erties in cancer cells [80]. During development, intercellular
adhesion is required for the maintenance of pluripotency in
embryonic stem cell populations, and its disruption leads to
the loss of stemness [81]. In a fascinating parallel to this devel-
opmental context, methylome profiling of breast CTCs found
that clusters, but not single cells, exhibited hypomethylation
of binding sites for numerous stem-associated transcription
factors [82]. Furthermore, the disruption of intercellular
adhesion in these clusters resulted in a reversal of hypomethyl-
ation at these sites, effectively reversing the stem-associated
profile in the constituent cells. It is therefore possible that
the further identification of developmentally relevant cell
adhesion molecules in stem cells will provide therapeutic
insights into the treatment of CTC clusters from multiple
carcinomas in the future.
Beyond the metastatic advantage provided by their resist-
ance to apoptosis [62,74], it is becoming increasingly clear
that the heterogeneity of CTC clusters enhances their potential
to colonize a distant site. Tumour cells within each cluster can
associatewith non-tumour cells that aid in their metastasis. For
example, lung cancer CTCs can incorporate tumour-associated
fibroblasts into their cluster, improving both the viability of the
tumour cells and themetastatic potential, likely throughmicro-
environmental alterations made by the fibroblasts to produce a
site amenable to further tumour growth [83]. Two recent
studies of CTC cluster composition identified additional inter-
actions with two populations of myeloid-derived immune
cells, both of which promoted metastasis through signalling
between tumour and immune cells to induce proliferation
[84,85]. Though it remains unproven, it is tempting to speculate
that heterogeneity may exist within the CTC cluster popula-
tion with respect to stemness traits. The adhesion between
heterogeneous cell populations within CTC clusters need not
necessarily rely on the same factors as those ensuring cohesion
between CTCs, as Vcam1 mutation disrupts the CTC–
neurophil interaction but not the interaction of CTC clusters
themselves [85]. These CTC clusters, and their associated
non-tumour cells, therefore migrate as a heterogeneous popu-
lation of cells with variations in fate, EMT state and potentially
stemness. It is likely that future studies turning to developmen-
talmodels of heterogeneous collectivemigration could identify
further factors required for adhesion and concerted migration
of CTC clusters, presenting potential targets for prognostic
and therapeutic use.
5. Understanding the relationship between
EMT and MET
While EMT can promote the dissemination of cancer cells from
primary tumours, an increasing number of studies point to a
key role for MET and the re-epithelialization of mesenchymal
cells in the growth of secondary tumours (figure 2c). Consider-
ing that MET is often described as the ‘reverse of EMT’, and
EMT has become a target of prime interest for anti-cancer
therapy [86], this raises an important question: is inhibiting
or removing EMT-inducing factors the same as promoting
MET? If so, this type of approach could have catastrophic
side-effects, driving metastatic progression in patients with
cells that have already disseminated from primary tumours.
The mechanisms driving MET are far less well understood
than those underlying EMT, and it remains unclear how the
mechanisms driving these processes relate to one another.
Rather than stimulating MET through activation of a specific
transcription factor or signalling pathway, in many in vitro
and in vivo cancer studiesMET is activated through the turning
off of an EMT-inducing signal such as transforming growth
factor β (TGF-β) [56,87], or through the downregulation of an
EMT-TF [88,89].
In line with this, in the few systems where MET has been
studied during tissue morphogenesis, EMT-TFs need to be
downregulated for MET to take place. Somite formation
relies on a cycle of EMT andMET, where presumptive paraxial
mesoderm cells transition to amesenchymal state as theymove
through the primitive streak, and later re-epithelialize as blocks
of tissues segregated from the anterior presomitic mesoderm
(figure 2b). Paraxial mesoderm cells maintain high levels of
snail1 and snail2 as theymigrate and form the presomitic meso-
derm [90]. However, both genes are downregulated as the cells
move from regions with high levels of fibroblast growth factor
(FGF) to those with low levels, and this coincides with their
acquisition of epithelial characteristics. It was demonstrated
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in chick that the overexpression of Snail2 blocks MET, with the
cells failing to express paraxis, a gene thought to be critical for
their re-epithelialization [90]. When considering the cycle of
EMT and MET that underlies embryonic midgut formation in
Drosophila, a similar relationship is seen. Endogenous Serpent
expression is downregulated in endoderm cells just after they
undergo EMTand initiate migration.When Serpent expression
is maintained in the cells, they never undergoMET and remain
mesenchymal throughout embryogenesis [26]. These results
support a central role for the downregulation of EMT-TFs in
order for MET to take place.
However, EMT-TF downregulation does not appear to be
sufficient for MET in these developmental contexts, which
also rely on interactions with neighbouring tissues. Removal
of the surface ectoderm, which lies adjacent to the somites,
results in a failure of the cells to undergo MET [91,92]. This is
not likely to be due to a failure in the downregulation of snail
genes, as this occurs downstream of changes in FGF levels,
which are independent of interactions with the ectoderm. Fur-
thermore, the initial expression of paraxis has been observed in
explants lacking ectoderm, suggesting that Snail is indeed
downregulated [93]. Instead, the ectoderm is required for the
deposition of a fibronectin matrix, which is absolutely critical
for the re-epithelialization of the somites [93,94]. Similarly,
MET in the Drosophila endoderm relies on interactions with
the underlying mesoderm [25], although whether this is
required for downregulating Serpent, or for providing
additional cues, remains to be explored.
Tissue–tissue interactions also play a role in the MET that
underlies the transition of the metanephric mesenchyme into
epithelial tubes, during morphogenesis of the vertebrate
kidney. MET in the metanephric mesenchyme relies on factors
secreted from the neighbouring ureteric bud, such as Wnt9b
andWnt4 [95,96]. In response to these signals, subpopulations
of the metanephric mesenchyme first condense into pretubular
aggregates, which then undergo MET, polarizing and forming
an intracellular lumen. Although it is not clear whether any
EMT-TFs are downregulated at this stage, it is interesting to
note that the subpopulation of the metanephric mesenchyme
that undergoes EMT is a self-renewing, multipotent Six2-
expressing progenitor population [97]. Six2 is essential for
maintaining the progenitor state, and suppresses epithelial
differentiation. Concordantly, Six2 loss results in premature
epithelialization of the metanephric mesenchyme in the
embryonic kidney, while ectopic expression of Six2 represses
the differentiation of mesenchymal cells into epithelia in a
kidney culture model [97]. Intriguingly, a more recent study
of Six2 in breast cancer found that Six2 expression is associated
with greater metastatic potential owing to both its induction of
ZEB2 expression and its repression of E-cadherin transcription
through promoter methylation [98]. It would be interesting to
explore if this mechanism also underlies the ability of Six2 to
block MET in the metanephric mesenchyme.
Interactions betweenmesenchymal cells and contacting tis-
sues are also important factors affecting MET during cancer
progression. It has long been recognized that while the proper-
ties of a single CTC, or a CTC cluster, are important
determinants inwhether it will succeed in forming ametastatic
outgrowth, the properties of the tissue in which CTCs attempt
colonization are equally important [99]. The outcome ofmetas-
tasis is dependent on cross-talk between tumour cells and
receptive tissues, and the ability to induce MET may form
part of this discourse. Crucially, it is becoming increasingly
clear that tumour cells are themselves capable of altering
these receptive tissues to their benefit. An elegant example of
this was recently demonstrated in a mouse model where the
so-called ‘metastatic initiating cells’ (MICs) were isolated
from the mouse breast cancer MMTV-PyMT model, tail-vein
injected, and the mechanisms underlying the formation of
resulting lung metastases investigated. It was found that colo-
nization of the lung relies on a cross-talk between the
mesenchymal MICs and the lung stroma. The MICs induced
activation of the lung fibroblasts through secretion of the extra-
cellular protein thrombospondin 2, and this in turn droveMET
in theMIC cells through the inhibition of TGF-β signalling [98].
Bone metastases in mouse models also demonstrate
tumour cell cross-talk with their receptive tissues, during
which MET is both induced in the tumour cells and required
for the development of secondary growths [100]. The bone vas-
cular niche, normally populated by haematopoietic progenitor
cells (HPCs) and haematopoietic stem cells (HSCs), represents
a common site for secondary metastases for breast cancer and
prostate cancer [101]. Evidence from mice suggests that pan-
creatic MICs use many of the same molecular pathways
normally used by HSCs to localize to the bone vascular niche
[101]. Of note is the role of E-selectin, which typically mediates
the capture of circulating HSCs and HPCs into the bone
marrow in a process called homing [102,103]. Metastatic cells
are able to repurpose this E-selectin binding as a means to
promote metastasis; in mouse models, metastatic breast
cancer cells were shown to undergo MET upon binding with
E-selectin expressed on the vascular endothelium [100].
E-selectin-induced MET did not affect the RNA expression of
master transcriptional regulators of EMT, such as Snail1/2,
Twist1/2 or ZEB1/2, instead appearing to affect EMT proteins
such asN-cadherin and Slug at the post-translational level. The
observations in this study point towards an MET programme
that is not the binary opposite of traditional EMT programmes,
which the authors suggest is a non-canonical MET [100].
The poor characterization of molecular drivers of MET
during metastatic colonization, and observations from studies
of metastasis such as those discussed above [100], raise the
question of what actually constitutes a canonical MET. There
are some suggestions from developmental contexts that the
mechanisms driving MET may be quite distinct from those
that were disassembled during EMT in the initial epithelium.
For example, in zebrafish embryos, repolarization of the
somites during MET is dependent on integrin α5 and the
extracellular matrix protein fibronectin [104]. However, neither
protein appears to play major roles in maintaining the
epithelial state during earlier stages of embryogenesis, as a
deficiency of either fibronectin or integrin α5 does not affect
axis elongation [104]. In Drosophila, Crumbs is a key regulator
of apicobasal polarity and adherens junction formation in the
first epithelium that forms in the embryo [105]. The transcrip-
tional repression of crumbs is the central mechanism by
which apicobasal polarity is disassembled during the EMT
that underlies endoderm formation [26]. However, Crumbs
and other apicobasal polarity proteins such as Stardust, the
Drosophila orthologue of Pals1, are never re-expressed in
the midgut, the sole endoderm derivative in Drosophila [106].
Furthermore, though the mechanisms underlying midgut
MET in the embryo are poorly understood, it has recently
been demonstrated that the cells in the adult midgut polarize
using an alternative mechanism, which does not appear
to require many of the factors required for polarity in the
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embryonic ectoderm—the epithelium fromwhich it is derived—
includingPar-3, Par-6, atypical protein kinaseC, Scribbled,Discs
large and Lethal giant larvae [107]. Additionally, while E-cad-
herin repression is central to EMT as cells move through the
primitive streak in vertebrates; it is not one of the key factors
involved in the MET that drives formation of the nephric
vesicles from the metanephric mesenchyme during kidney
morphogenesis. Instead, afadin, a nectin adaptor protein, is
required for de novo lumen formation in vivo, acting upstream
of the recruitment and/or stabilization of the predominant cad-
herin, R-cadherin, during repolarization of renal vesicles [108].
Thus, in the fewdevelopmental systemswhere it has been exam-
ined indetail, repolarizationandre-epithelializationappear tobe
driven by mechanisms distinct from those underlying the
original transition towards a mesenchymal state.
Recent studies examining EMP during cancer progression
also suggest that EMT and MET are not simply the reverse
of one another. Single-cell cytometry of lung cancer samples
demonstrated that cells that undergo sequential EMT and
MET, induced by TGF-β treatment and withdrawal, respect-
ively, undergo transitions following distinct branched
trajectories that do not mirror each other [56]. Moreover,
successive EMT/MET in epithelial cancers appear to promote
re-epithelialization through alternative pathways, such that
the cells do not re-acquire traits of their previous epithelial
cell state, and epithelial tumour cells after EMT/MET often
demonstrate greater tumorigenic potential. For example,
studies of patient tissue found that all metastatic tumours orig-
inating from ductal carcinoma expressed or re-expressed E-
cadherin, irrespective of the E-cadherin status of the primary
breast tumour, demonstrating differential expression of E-cad-
herin in epithelial tumour cells following MET compared with
before EMT onset [109]. Additionally, RNA-seq of in vivo
models of bonemetastases showed that followingMET, specific
subsets of genes that promoted establishment of a metastatic
niche were upregulated [87]. Furthermore, re-epithelialized
prostate cancer cell lines transformed by transient induction
of Snail exhibited a specific transcriptional signature which
was lacking in untreated epithelial cells [89]. The clusters of
genes differentially expressed in the re-epithelialized cells
were associated with poor prognosis in various cancers and
castrate resistance in prostate cancer, illustrating the dramatic
difference in transcription profile and metastatic potential
between epithelial cancer cells pre- and post-MET [89]. These
distinctions between cell state following EMT/MET and cell
state in epithelial cells prior to EMT challenge the paradigm
that EMT and MET are reverse processes, and may be indica-
tive of different regulatory mechanisms (figure 3). Taken
together, this suggests that rather than pursuing a strategy of
blocking EMT through targeting of an EMT-TF or its cofactor,
which may prime already-disseminated CTCs to undergo
MET in response to local cues in the environment, it may be
better to focus on identifying mechanisms unique to either
EMT or MET, as these could present more specific targets for
therapeutic intervention.
6. Conclusion and future perspectives
Since the initial characterizations of EMP in the developing
embryo [12], several principles relating to the nature of the
underlying transitions, and their relation to one another, have
been identified and investigated in both cancer and develop-
ment. These joint studies have, in recent years, resulted in
the emergence of several parallel concepts. Examinations
ofmorphogenesis andpathogenesis have, for example, demon-
strated that EMT and MET are not simply transitions between
two endpoints, but multifaceted and diverse programmes
epithelial
epithelial2
epithelial1
intermediate
EM1
intermediate
EM2
mesenchymal
mesenchymal
Figure 3. EMP occurs along branched trajectories to produce divergent cell fates. The extent to which EMT is activated, and the nature of the epithelial cell in which
EMT is induced, results in a broad spectrum of partial EMT states. However, given that MET is not simply the reversal of the EMT process, the end result of this
programme is not a reversion to the initial epithelial state (yellow with black nucleus) but the adoption of a second, distinct epithelial cell fate (yellow with red
nucleus). It is worth noting that, though the arrows in this diagram indicate a complete progression through to a fully mesenchymal state prior to MET, it is also
possible for cells exhibiting a partial EMT to undergo MET towards a second epithelial state, effectively bypassing full EMT.
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activated to varying degrees, creating a continuum of partial
epithelial and mesenchymal cell states [7]. The increasing
diversity of observed EMT states in cancer, coupled with an
increasing appreciation of their clinical relevance, necessitates
their further interrogation in the pursuit of novel therapies.
Additionally, the fields of cancer research and develop-
ment appear to be converging—albeit through different
lenses—on the concept that EMT and MET are not merely
inverse processes. This view, which suggests that MET does
not result in reversion to the initial epithelial state but in
the adoption of a new and divergent epithelial fate (figure 3),
is supported by transcriptional analysis of metastatic cells, as
well as morphological and genetic studies during develop-
ment [56,87,89,104,106,108]. Such a concept may prove
therapeutically useful if the gene signatures or requirements
specific to cancer MET during metastasis can be identified
and disrupted.
However, in spite of these emerging concepts, advances
in understanding the epithelial–mesenchymal trajectories fol-
lowed by tumours—from primary growth to tissue escape to
metastasis—are often stymied by the constraints of animal
tumour models, from their genetic inflexibility to their diffi-
culty to image over the course of tumour progression
[73,110]. Developmental models have now been identified
in which EMT, migration and MET can be investigated in
the same cell population, enabling the study of how each of
these steps relates to each other. Invertebrate and lower ver-
tebrate models in particular are amenable to in vivo live
imaging at the subcellular resolution, allowing dynamic
changes to cell morphology and behaviour to be observed
over time [26,43,111]. Additionally, these provide a genetic
tractability that allows the intricate dissection of different sig-
nals and pathways that play roles in these processes, and the
contributions their disruption may make to aberrant
behaviours such as tumour formation. It seems advan-
tageous, therefore, for developmental models to be adopted
as additional methods for the study of the EMT spectrum
and migration, when trying to understand the cellular and
molecular dynamics of these processes in tumorigenesis.
Excitingly, the increasing use of single-cell sequencing tech-
nology may also help to further bridge the gap between
developmental and cancer models. The use of single-cell analy-
sis has contributed significantly to the understanding of the
diversity and functional relevance of partial EMT states and
MET-associated gene signatures in cancer [54–56,82,87,89,112].
Single-cell methods are also being used to better understand
the processes underlying normal development, and to identify
novel cell populations and lineages [113]. These studies provide
a unique opportunity; if these data from single-cell studies in
development and cancer are considered in tandem, it may aid
in the identification of developmental systems that are well-
suited to act as models for the progression of specific cancer
types. This pairing of models with one another could be under-
taken on the basis of shared marker expression, gene cluster
upregulation or stemness traits, and allow greater overlap and
collaboration between the fields of development and cancer
research, to their mutual benefit.
Data accessibility. This article has no additional data.
Authors’ contributions. A.T.P., S.K. and K.C. conceived the idea behind the
review, and drafted, revised and wrote the review together. S.K.
designed the figures. All authors gave final approval for publication.
Competing interests. We declare we have no competing interests.
Funding. This work was supported by a Wellcome Trust/Royal Society
Sir Henry Dale Fellowship (grant no. 204615/Z/16/Z).
Acknowledgements. We are thankful to the rest of the Campbell lab, the
Bulgakova lab and Andreu Casali for helpful discussions, and to
Áine and Gordon Campbell for providing essential support.
References
1. Thiery JP, Acloque H, Huang RYJ, Nieto MA. 2009
Epithelial-mesenchymal transitions in development
and disease. Cell 139, 871–890. (doi:10.1016/j.cell.
2009.11.007)
2. Nieto MA, Huang RYYJ, Jackson RAA, Thiery JPP.
2016 EMT: 2016. Cell 166, 21–45. (doi:10.1016/j.
cell.2016.06.028)
3. Antonello ZA, Reiff T, Ballesta-Illan E, Dominguez M.
2015 Robust intestinal homeostasis relies on cellular
plasticity in enteroblasts mediated by miR-8–
Escargot switch. EMBO J. 34, 2025–2041. (doi:10.
15252/embj.201591517)
4. Shibue T, Weinberg RA. 2017 EMT, CSCs, and drug
resistance: the mechanistic link and clinical
implications. Nat. Rev. Clin. Oncol. 14, 611–629.
(doi:10.1038/nrclinonc.2017.44)
5. Derynck R, Weinberg RA. 2019 EMT and cancer:
more than meets the eye. Dev. Cell 49, 313–316.
(doi:10.1016/j.devcel.2019.04.026)
6. Lambert AW, Pattabiraman DR, Weinberg RA.
2017 Emerging biological principles of
metastasis. Cell 168, 670–691. (doi:10.1016/j.cell.
2016.11.037)
7. Campbell K, Casanova J. 2016 A common
framework for EMT and collective cell migration.
Development 143, 4291–4300. (doi:10.1242/dev.
139071)
8. Janiszewska M, Primi MC, Izard T. 2020 Cell
adhesion in cancer: beyond the migration of single
cells. J. Biol. Chem. 295, 2495–2505. (doi:10.1074/
jbc.REV119.007759)
9. St Johnston D. 2018 Establishing and transducing cell
polarity: common themes and variations. Curr. Opin.
Cell Biol. 51, 33–41. (doi:10.1016/j.ceb.2017.10.007)
10. Yurchenco PD. 2011 Basement membranes: cell
scaffoldings and signaling platforms. Cold Spring
Harb. Perspect. Biol. 3, a004911. (doi:10.1101/
cshperspect.a004911)
11. Yang J et al. 2020 Guidelines and definitions for
research on epithelial–mesenchymal transition. Nat.
Rev. Mol. Cell Biol. 21, 341–352. (doi:10.1038/
s41580-020-0237-9)
12. Hay ED. 1968 Epithelial–Mesenchymal Interactions:
18th Hahnemann Symposium (ed. R Fleischmajer,
RE Billingham), pp. 31–35. Baltimore, MD: Williams
and Wilkins.
13. Nieto MA, Sargent MG, Wilkinson DG, Cooke J. 1994
Control of cell behavior during vertebrate
development by Slug, a zinc finger gene. Science
264, 835–839. (doi:10.1126/science.7513443)
14. Batlle E, Sancho E, Franci C, Dominguez D, Monfar
M, Baulida J, Garcia De Herreros A. 2000 The
transcription factor Snail is a repressor of E-cadherin
gene expression in epithelial tumour cells. Nat. Cell
Biol. 2, 84–89. (doi:10.1038/35000034)
15. Boulay JL, Dennefeld C, Alberga A. 1987 The
Drosophila developmental gene snail encodes a
protein with nucleic acid binding fingers. Nature
330, 395–398. (doi:10.1038/330395a0)
16. Thisse B, Stoetzel C, Gorostiza-Thisse C, Perrin-
Schmitt F. 1988 Sequence of the twist gene and
nuclear localization of its protein in
endomesodermal cells of early Drosophila embryos.
EMBO J. 7, 2175–2183.
17. Funahashi J, Sekido R, Murai K, Kamachi Y, Kondoh
H. 1993 Delta-crystallin enhancer binding protein
delta EF1 is a zinc finger-homeodomain protein
implicated in postgastrulation embryogenesis.
Development 119, 433–446.
royalsocietypublishing.org/journal/rstb
Phil.
Trans.
R.
Soc.
B
375:
20200087
9
18. Martin JF, Bradley A, Olson EN. 1995 The paired-like
homeo box gene MHox is required for early events
of skeletogenesis in multiple lineages. Genes Dev. 9,
1237–1249. (doi:10.1101/gad.9.10.1237)
19. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A,
Blanco MJ, del Barrio MG, Portillo F, Nieto MA. 2000
The transcription factor Snail controls epithelial–
mesenchymal transitions by repressing E-cadherin
expression. Nat. Cell Biol. 2, 76–83. (doi:10.1038/
35000025)
20. Lamouille S, Xu J, Derynck R. 2014 Molecular
mechanisms of epithelial–mesenchymal transition.
Nat. Rev. Mol. Cell Biol. 15, 178–196. (doi:10.1038/
nrm3758)
21. Stemmler MP, Eccles RL, Brabletz S, Brabletz T. 2019
Non-redundant functions of EMT transcription
factors. Nat. Cell Biol. 21, 102–112. (doi:10.1038/
s41556-018-0196-y)
22. Oda H, Tsukita S, Takeichi M. 1998 Dynamic
behavior of the cadherin-based cell–cell adhesion
system during Drosophila gastrulation. Dev. Biol.
203, 435–450. (doi:10.1006/dbio.1998.9047)
23. Leptin M. 1991 twist and snail as positive and
negative regulators during Drosophila mesoderm
development. Genes Dev. 5, 1568–1576. (doi:10.
1101/gad.5.9.1568)
24. Reuter R, Leptin M. 1994 Interacting functions of
snail, twist and huckebein during the early
development of germ layers in Drosophila.
Development 120, 1137–1150.
25. Tepass U, Hartenstein V. 1994 Epithelium formation
in the Drosophila midgut depends on the
interaction of endoderm and mesoderm.
Development 120, 579–590.
26. Campbell K, Whissell G, Franch-Marro X, Batlle E,
Casanova J. 2011 Specific GATA factors act as conserved
inducers of an endodermal-EMT. Dev. Cell 21,
1051–1061. (doi:10.1016/j.devcel.2011.10.005)
27. Gouignard N, Andrieu C, Theveneau E. 2018 Neural
crest delamination and migration: looking forward
to the next 150 years. Genesis 56, e23107. (doi:10.
1002/dvg.23107)
28. Lander R, Nasr T, Ochoa SD, Nordin K, Prasad MS,
LaBonne C. 2013 Interactions between Twist and
other core epithelial–mesenchymal transition
factors are controlled by GSK3-mediated
phosphorylation. Nat. Commun. 4, 1542. (doi:10.
1038/ncomms2543)
29. Mayor R, Morgan R, Sargent MG. 1995 Induction of
the prospective neural crest of Xenopus.
Development 121, 767–777.
30. Dady A, Blavet C, Duband J-L. 2012 Timing and
kinetics of E- to N-cadherin switch during
neurulation in the avian embryo. Dev. Dyn. 241,
1333–1349. (doi:10.1002/dvdy.23813)
31. Simões-Costa M, Tan-Cabugao J, Antoshechkin I,
Sauka-Spengler T, Bronner ME. 2014 Transcriptome
analysis reveals novel players in the cranial neural
crest gene regulatory network. Genome Res. 24,
281–290. (doi:10.1101/gr.161182.113)
32. Théveneau E, Duband J-L, Altabef M. 2007 Ets-1
confers cranial features on neural crest
delamination. PLoS ONE 2, e1142. (doi:10.1371/
journal.pone.0001142)
33. Tran HD, Luitel K, Kim M, Zhang K, Longmore GD,
Tran DD. 2014 Transient SNAIL1 expression is
necessary for metastatic competence in breast
cancer. Cancer Res. 74, 6330–6340. (doi:10.1158/
0008-5472.CAN-14-0923)
34. Vincent T et al. 2009 A SNAIL1–SMAD3/4
transcriptional repressor complex promotes TGF-β
mediated epithelial–mesenchymal transition. Nat.
Cell Biol. 11, 943–950. (doi:10.1038/ncb1905)
35. Kahlert C et al. 2011 Overexpression of ZEB2 at the
invasion front of colorectal cancer is an independent
prognostic marker and regulates tumor invasion in
vitro. Clin. Cancer Res. 17, 7654–7663. (doi:10.
1158/1078-0432.CCR-10-2816)
36. Zheng X, Carstens JL, Kim J, Scheible M, Kaye J,
Sugimoto H, Wu C-C, LeBleu VS, Kalluri R. 2015
Epithelial-to-mesenchymal transition is dispensable
for metastasis but induces chemoresistance in
pancreatic cancer. Nature 527, 525–530. (doi:10.
1038/nature16064)
37. Krebs AM et al. 2017 The EMT-activator Zeb1 is a
key factor for cell plasticity and promotes metastasis
in pancreatic cancer. Nat. Cell Biol. 19, 518–529.
(doi:10.1038/ncb3513)
38. Latil M et al. 2017 Cell-type-specific chromatin
states differentially prime squamous cell carcinoma
tumor-initiating cells for epithelial to mesenchymal
transition. Cell Stem Cell 20, 191–204. (doi:10.1016/
j.stem.2016.10.018)
39. Chen T, Heller E, Beronja S, Oshimori N, Stokes N,
Fuchs E. 2012 An RNA interference screen uncovers
a new molecule in stem cell self-renewal and long-
term regeneration. Nature 485, 104–108. (doi:10.
1038/nature10940)
40. Osorio KM, Lee SE, McDermitt DJ, Waghmare SK,
Zhang YV, Woo HN, Tumbar T. 2008 Runx1
modulates developmental, but not injury-driven,
hair follicle stem cell activation. Development 135,
1059–1068. (doi:10.1242/dev.012799)
41. Tepass U, Hartenstein V. 1995 Neurogenic and
proneural genes control cell fate specification
in the Drosophila endoderm. Development 121,
393–405.
42. Reuter R, Grunewald B, Leptin M. 1993 A role for
the mesoderm in endodermal migration and
morphogenesis in Drosophila. Development 119,
1135–1145.
43. Campbell K, Casanova J. 2015 A role for E-cadherin
in ensuring cohesive migration of a heterogeneous
population of non-epithelial cells. Nat. Commun. 6,
7998. (doi:10.1038/ncomms8998)
44. Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris
JS, Lippman SM. 2007 The transcription factor
GATA-6 is overexpressed in vivo and contributes to
silencing 15-LOX-1 in vitro in human colon cancer.
FASEB J. 21, 743–753. (doi:10.1096/fj.06-6830com)
45. Kwei KA et al. 2008 Genomic profiling identifies
GATA6 as a candidate oncogene amplified in
pancreatobiliary cancer. PLoS Genet. 4, e1000081.
(doi:10.1371/journal.pgen.1000081)
46. Martinelli P et al. 2017 GATA6 regulates EMT and
tumour dissemination, and is a marker of response
to adjuvant chemotherapy in pancreatic cancer. Gut
66, 1665–1676. (doi:10.1136/gutjnl-2015-311256)
47. Cai D, Chen S-C, Prasad M, He L, Wang X,
Choesmel-Cadamuro V, Sawyer JK, Danuser G,
Montell DJ. 2014 Mechanical feedback through
E-cadherin promotes direction sensing during
collective cell migration. Cell 157, 1146–1159.
(doi:10.1016/j.cell.2014.03.045)
48. Dumortier JG, Martin S, Meyer D, Rosa FM,
David NB. 2012 Collective mesendoderm migration
relies on an intrinsic directionality signal
transmitted through cell contacts. Proc. Natl. Acad.
Sci. USA 109, 16 945–16 950. (doi:10.1073/pnas.
1205870109)
49. Montero J-A, Carvalho L, Wilsch-Brauninger M,
Kilian B, Mustafa C, Heisenberg C-P. 2005 Shield
formation at the onset of zebrafish gastrulation.
Development 132, 1187–1198. (doi:10.1242/dev.
01667)
50. Scarpa E, Szabó A, Bibonne A, Theveneau E, Parsons
M, Mayor R. 2015 Cadherin switch during EMT in
neural crest cells leads to contact inhibition of
locomotion via repolarization of forces. Dev. Cell 34,
421–434. (doi:10.1016/j.devcel.2015.06.012)
51. Huang C, Kratzer M-C, Wedlich D, Kashef J. 2016
E-cadherin is required for cranial neural crest
migration in Xenopus laevis. Dev. Biol. 411,
159–171. (doi:10.1016/j.ydbio.2016.02.007)
52. Lee RTH, Nagai H, Nakaya Y, Sheng G, Trainor PA,
Weston JA, Thiery JP. 2013 Cell delamination in the
mesencephalic neural fold and its implication for
the origin of ectomesenchyme. Development 140,
4890–4902. (doi:10.1242/dev.094680)
53. Tarin D. 2005 The fallacy of epithelial mesenchymal
transition in neoplasia. Cancer Res. 65, 5996–6001.
(doi:10.1158/0008-5472.CAN-05-0699)
54. Pastushenko I et al. 2018 Identification of the
tumour transition states occurring during EMT.
Nature 556, 463–468. (doi:10.1038/s41586-018-
0040-3)
55. Gonzalez VD et al. 2018 Commonly occurring cell
subsets in high-grade serous ovarian tumors
identified by single-cell mass cytometry. Cell Rep.
22, 1875–1888. (doi:10.1016/j.celrep.2018.01.053)
56. Karacosta LG, Anchang B, Ignatiadis N, Kimmey SC,
Benson JA, Shrager JB, Tibshirani R, Bendall SC,
Plevritis SK. 2019 Mapping lung cancer epithelial-
mesenchymal transition states and trajectories with
single-cell resolution. Nat. Commun. 10, 5587.
(doi:10.1038/s41467-019-13441-6)
57. Jolly MK et al. 2019 Hybrid epithelial/mesenchymal
phenotypes promote metastasis and therapy
resistance across carcinomas. Pharmacol. Ther. 194,
161–184. (doi:10.1016/j.pharmthera.2018.09.007)
58. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ,
van de Vijver M, Cornelisse C, van Roy F. 1995
E-cadherin is a tumour/invasion suppressor gene
mutated in human lobular breast cancers. EMBO J.
14, 6107–6115. (doi:10.1002/j.1460-2075.1995.
tb00301.x)
royalsocietypublishing.org/journal/rstb
Phil.
Trans.
R.
Soc.
B
375:
20200087
10
59. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F,
Kunz-Schughart LA, Knuechel R, Kirchner T. 2001
Variable β-catenin expression in colorectal
cancers indicates tumor progression driven
by the tumor environment. Proc. Natl Acad.
Sci. USA 98, 10 356–10 361. (doi:10.1073/pnas.
171610498)
60. Derksen PWB et al. 2006 Somatic inactivation of
E-cadherin and p53 in mice leads to metastatic
lobular mammary carcinoma through induction of
anoikis resistance and angiogenesis. Cancer Cell 10,
437–449. (doi:10.1016/j.ccr.2006.09.013)
61. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES,
Weinberg RA. 2008 Loss of E-cadherin promotes
metastasis via multiple downstream transcriptional
pathways. Cancer Res. 68, 3645–3654. (doi:10.
1158/0008-5472.CAN-07-2938)
62. Padmanaban V, Krol I, Suhail Y, Szczerba BM,
Aceto N, Bader JS, Ewald AJ. 2019 E-cadherin is
required for metastasis in multiple models of breast
cancer. Nature 573, 439–444. (doi:10.1038/s41586-
019-1526-3)
63. Reichert M et al. 2018 Regulation of epithelial
plasticity determines metastatic organotropism in
pancreatic cancer. Dev. Cell 45, 696–711. (doi:10.
1016/j.devcel.2018.05.025)
64. Aiello NM et al. 2018 EMT subtype influences
epithelial plasticity and mode of cell migration.
Dev. Cell 45, 681–695. (doi:10.1016/j.devcel.2018.
05.027)
65. Song S, Eckerle S, Onichtchouk D, Marrs JA,
Nitschke R, Driever W. 2013 Pou5f1-dependent
EGF expression controls E-cadherin endocytosis,
cell adhesion, and zebrafish epiboly movements.
Dev. Cell 24, 486–501. (doi:10.1016/j.devcel.2013.
01.016)
66. Wu S-Y, McClay DR. 2007 The Snail repressor is
required for PMC ingression in the sea urchin
embryo. Development 134, 1061–1070. (doi:10.
1242/dev.02805)
67. Friedl P, Locker J, Sahai E, Segall JE. 2012
Classifying collective cancer cell invasion.
Nat. Cell Biol. 14, 777–783. (doi:10.1038/
ncb2548)
68. Cheung KJ, Gabrielson E, Werb Z, Ewald AJ. 2013
Collective invasion in breast cancer requires a
conserved basal epithelial program. Cell 155,
1639–1651. (doi:10.1016/j.cell.2013.11.029)
69. Cheung KJ et al. 2016 Polyclonal breast cancer
metastases arise from collective dissemination of
keratin 14-expressing tumor cell clusters. Proc. Natl
Acad. Sci. USA 113, E854–E863. (doi:10.1073/pnas.
1508541113)
70. Campbell K, Rossi F, Adams J, Pitsidianaki I, Barriga
FM, Garcia-Gerique L, Batlle E, Casanova J, Casali A.
2019 Collective cell migration and metastases
induced by an epithelial-to-mesenchymal transition
in Drosophila intestinal tumors. Nat. Commun. 10,
2311. (doi:10.1038/s41467-019-10269-y)
71. Bronsert P et al. 2014 Cancer cell invasion and EMT
marker expression: a three-dimensional study of the
human cancer–host interface. J. Pathol. 234,
410–422. (doi:10.1002/path.4416)
72. Khalil AA, Ilina O, Gritsenko PG, Bult P, Span PN,
Friedl P. 2017 Collective invasion in ductal and
lobular breast cancer associates with distant
metastasis. Clin. Exp. Metastasis 34, 421–429.
(doi:10.1007/s10585-017-9858-6)
73. Ilina O, Campanello L, Gritsenko PG, Vullings M,
Wang C, Bult P, Losert W, Friedl P. 2018 Intravital
microscopy of collective invasion plasticity in breast
cancer. Dis. Model. Mech. 11, dmm034330. (doi:10.
1242/dmm.034330)
74. Aceto N et al. 2014 Circulating tumor cell clusters
are oligoclonal precursors of breast cancer
metastasis. Cell 158, 1110–1122. (doi:10.1016/j.cell.
2014.07.013)
75. Yu M et al. 2013 Circulating breast tumor cells
exhibit dynamic changes in epithelial and
mesenchymal composition. Science 339, 580–584.
(doi:10.1126/science.1228522)
76. Cheung KJ, Ewald AJ. 2016 A collective route to
metastasis: seeding by tumor cell clusters. Science
352, 167–169. (doi:10.1126/science.aaf6546)
77. Giuliano M, Shaikh A, Lo HC, Arpino G, De Placido S,
Zhang XH, Cristofanilli M, Schiff R, Trivedi MV. 2018
Perspective on circulating tumor cell clusters: why it
takes a village to metastasize. Cancer Res. 78,
845–852. (doi:10.1158/0008-5472.CAN-17-2748)
78. Li C-F et al. 2019 Snail-induced claudin-11 prompts
collective migration for tumour progression. Nat.
Cell Biol. 21, 251–262. (doi:10.1038/s41556-018-
0268-z)
79. Liu X et al. 2019 Homophilic CD44 interactions
mediate tumor cell aggregation and polyclonal
metastasis in patient-derived breast cancer models.
Cancer Discov. 9, 96–113. (doi:10.1158/2159-8290.
CD-18-0065)
80. Mani SA et al. 2008 The epithelial-mesenchymal
transition generates cells with properties of
stem cells. Cell 133, 704–715. (doi:10.1016/j.cell.
2008.03.027)
81. Pieters T, van Roy F. 2014 Role of cell–cell adhesion
complexes in embryonic stem cell biology. J. Cell Sci.
127, 2603–2613. (doi:10.1242/jcs.146720)
82. Gkountela S et al. 2019 Circulating tumor cell
clustering shapes DNA methylation to enable
metastasis seeding. Cell 176, 98–112. (doi:10.1016/
j.cell.2018.11.046)
83. Duda DG, Duyverman AMMJ, Kohno M, Snuderl M,
Steller EJA, Fukumura D, Jain RK. 2010 Malignant
cells facilitate lung metastasis by bringing their own
soil. Proc. Natl Acad. Sci. USA 107, 21 677–21 682.
(doi:10.1073/pnas.1016234107)
84. Sprouse ML et al. 2019 PMN-MDSCs enhance CTC
metastatic properties through reciprocal interactions
via ROS/Notch/Nodal signaling. Int. J. Mol. Sci. 20,
1916. (doi:10.3390/ijms20081916)
85. Szczerba BM et al. 2019 Neutrophils escort
circulating tumour cells to enable cell cycle
progression. Nature 566, 553–557. (doi:10.1038/
s41586-019-0915-y)
86. Marcucci F, Stassi G, De Maria R. 2016 Epithelial–
mesenchymal transition: a new target in anticancer
drug discovery. Nat. Rev. Drug Discov. 15, 311–325.
(doi:10.1038/nrd.2015.13)
87. Shinde A, Paez JS, Libring S, Hopkins K, Solorio L,
Wendt MK. 2020 Transglutaminase-2 facilitates
extracellular vesicle-mediated establishment of the
metastatic niche. Oncogenesis 9, 16. (doi:10.1038/
s41389-020-0204-5)
88. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J.
2012 Spatiotemporal regulation of epithelial-
mesenchymal transition is essential for squamous
cell carcinoma metastasis. Cancer Cell 22, 725–736.
(doi:10.1016/j.ccr.2012.09.022)
89. Stylianou N et al. 2019 A molecular portrait of
epithelial–mesenchymal plasticity in prostate cancer
associated with clinical outcome. Oncogene 38,
913–934. (doi:10.1038/s41388-018-0488-5)
90. Dale JK et al. 2006 Oscillations of the Snail genes in
the presomitic mesoderm coordinate segmental
patterning and morphogenesis in vertebrate
somitogenesis. Dev. Cell 10, 355–366. (doi:10.1016/
j.devcel.2006.02.011)
91. Sosic D, Brand-Saberi B, Schmidt C, Christ B, Olson
EN. 1997 Regulation of paraxis expression and
somite formation by ectoderm- and neural tube-
derived signals. Dev. Biol. 185, 229–243. (doi:10.
1006/dbio.1997.8561)
92. Correia KM, Conlon RA. 2000 Surface ectoderm is
necessary for the morphogenesis of somites. Mech.
Dev. 91, 19–30. (doi:10.1016/s0925-4773(99)
00260-9)
93. Rifes P, Carvalho L, Lopes C, Andrade RP, Rodrigues
G, Palmeirim I, Thorsteinsdóttir S. 2007 Redefining
the role of ectoderm in somitogenesis: a player in
the formation of the fibronectin matrix of
presomitic mesoderm. Development 134,
3155–3165. (doi:10.1242/dev.003665)
94. Girós A, Grgur K, Gossler A, Costell M. 2011 α5β1
integrin-mediated adhesion to fibronectin is
required for axis elongation and somitogenesis in
mice. PLoS ONE 6, e22002. (doi:10.1371/journal.
pone.0022002)
95. Carroll TJ, Park J-S, Hayashi S, Majumdar A,
McMahon AP. 2005 Wnt9b plays a central role in
the regulation of mesenchymal to epithelial
transitions underlying organogenesis of the
mammalian urogenital system. Dev. Cell 9,
283–292. (doi:10.1016/j.devcel.2005.05.016)
96. Park J-S, Valerius MT, McMahon AP. 2007
Wnt/β-catenin signaling regulates nephron
induction during mouse kidney development.
Development 134, 2533–2539. (doi:10.1242/
dev.006155)
97. Self M, Lagutin OV, Bowling B, Hendrix J, Cai Y,
Dressler GR, Oliver G. 2006 Six2 is required for
suppression of nephrogenesis and progenitor
renewal in the developing kidney. EMBO J. 25,
5214–5228. (doi:10.1038/sj.emboj.7601381)
98. Wang C-A et al. 2014 Homeoprotein Six2 promotes
breast cancer metastasis via transcriptional and
epigenetic control of E-cadherin expression. Cancer
Res. 74, 7357–7370. (doi:10.1158/0008-5472.CAN-
14-0666)
99. Fidler IJ, Poste G. 2008 The ‘seed and soil’
hypothesis revisited. Lancet Oncol. 9, 808. (doi:10.
1016/S1470-2045(08)70201-8)
royalsocietypublishing.org/journal/rstb
Phil.
Trans.
R.
Soc.
B
375:
20200087
11
100. Esposito M et al. 2019 Bone vascular niche
E-selectin induces mesenchymal–epithelial
transition and Wnt activation in cancer cells to
promote bone metastasis. Nat. Cell Biol. 21,
627–639. (doi:10.1038/s41556-019-0309-2)
101. Shiozawa Y et al. 2011 Human prostate cancer
metastases target the hematopoietic stem cell niche
to establish footholds in mouse bone marrow.
J. Clin. Invest. 121, 1298–1312. (doi:10.1172/
JCI43414)
102. Frenette PS, Subbarao S, Mazo IB, von Andrian UH,
Wagner DD. 1998 Endothelial selectins and vascular cell
adhesion molecule-1 promote hematopoietic progenitor
homing to bone marrow. Proc. Natl Acad. Sci. USA 95,
14 423–14 428. (doi:10.1073/pnas.95.24.14423)
103. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein
R. 2001 CD44 is a major E-selectin ligand on human
hematopoietic progenitor cells. J. Cell Biol. 153,
1277–1286. (doi:10.1083/jcb.153.6.1277)
104. Koshida S, Kishimoto Y, Ustumi H, Shimizu T,
Furutani-Seiki M, Kondoh H, Takada S. 2005
Integrinα5-dependent fibronectin accumulation for
maintenance of somite boundaries in zebrafish
embryos. Dev. Cell 8, 587–598. (doi:10.1016/j.
devcel.2005.03.006)
105. Wodarz A, Grawe F, Knust E. 1993 CRUMBS is
involved in the control of apical protein targeting
during Drosophila epithelial development. Mech.
Dev. 44, 175–187. (doi:10.1016/0925-
4773(93)90066-7)
106. Tepass U. 1997 Epithelial differentiation in
Drosophila. Bioessays 19, 673–682. (doi:10.1002/
bies.950190807)
107. Chen J, Sayadian A-C, Lowe N, Lovegrove HE, St
Johnston D. 2018 An alternative mode of
epithelial polarity in the Drosophila midgut.
PLoS Biol. 16, e3000041. (doi:10.1371/journal.
pbio.3000041)
108. Yang Z, Zimmerman S, Brakeman PR, Beaudoin GM,
Reichardt LF, Marciano DK. 2013 De novo lumen
formation and elongation in the developing
nephron: a central role for afadin in apical polarity.
Development 140, 1774–1784. (doi:10.1242/dev.
087957)
109. Kowalski PJ, Rubin MA, Kleer CG. 2003 E-cadherin
expression in primary carcinomas of the breast and
its distant metastases. Breast Cancer Res. 5,
R217–R222. (doi:10.1186/bcr651)
110. Gengenbacher N, Singhal M, Augustin HG. 2017
Preclinical mouse solid tumour models: status quo,
challenges and perspectives. Nat. Rev. Cancer 17,
751–765. (doi:10.1038/nrc.2017.92)
111. Theveneau E, Steventon B, Scarpa E, Garcia S,
Trepat X, Streit A, Mayor R. 2013 Chase-
and-run between adjacent cell populations
promotes directional collective migration.
Nat. Cell Biol. 15, 763–772. (doi:10.1038/
ncb2772)
112. Praktiknjo SD et al. 2020 Tracing tumorigenesis in a
solid tumor model at single-cell resolution. Nat.
Commun. 11, 991. (doi:10.1038/s41467-020-
14777-0)
113. McKenna A, Gagnon JA. 2019 Recording
development with single cell dynamic lineage
tracing. Development 146, dev169730. (doi:10.1242/
dev.169730)
royalsocietypublishing.org/journal/rstb
Phil.
Trans.
R.
Soc.
B
375:
20200087
12
